×
Entrez Id: 3569
Gene Symbol: IL6
IL6
Prostatic Neoplasms
0.400
Biomarker
LHGDN
Annexin A2 positively contributes to the malignant phenotype and secretion of IL-6 in DU145 prostate cancer cells.
18924133 2009
×
Entrez Id: 3569
Gene Symbol: IL6
IL6
Prostatic Neoplasms
0.400
Biomarker
LHGDN
p38MAPK activation is involved in androgen-independent proliferation of human prostate cancer cells by regulating IL-6 secretion.
17196171 2007
×
Entrez Id: 3569
Gene Symbol: IL6
IL6
Prostatic Neoplasms
0.400
Biomarker
LHGDN
Interleukin-6 undergoes transition from growth inhibitor associated with neuroendocrine differentiation to stimulator accompanied by androgen receptor activation during LNCaP prostate cancer cell progression.
17373716 2007
×
Entrez Id: 3569
Gene Symbol: IL6
IL6
Prostatic Neoplasms
0.400
Biomarker
LHGDN
Interleukin-6 activates PI3K/Akt pathway and regulates cyclin A1 to promote prostate cancer cell survival.
18027847 2008
×
Entrez Id: 3569
Gene Symbol: IL6
IL6
Prostatic Neoplasms
0.400
Biomarker
LHGDN
The Fer tyrosine kinase cooperates with interleukin-6 to activate signal transducer and activator of transcription 3 and promote human prostate cancer cell growth.
19147545 2009
×
Entrez Id: 3569
Gene Symbol: IL6
IL6
Prostatic Neoplasms
0.400
GeneticVariation
LHGDN
Interleukin-6 polymorphism is associated with more aggressive prostate cancer.
16006970 2005
×
Entrez Id: 3569
Gene Symbol: IL6
IL6
Prostatic Neoplasms
0.400
AlteredExpression
LHGDN
Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer.
12727841 2003
×
Entrez Id: 3569
Gene Symbol: IL6
IL6
Prostatic Neoplasms
0.400
AlteredExpression
LHGDN
Synergism of cytoplasmic kinases in IL6-induced ligand-independent activation of androgen receptor in prostate cancer cells.
14981536 2004
×
Entrez Id: 3569
Gene Symbol: IL6
IL6
Prostatic Neoplasms
0.400
Biomarker
LHGDN
Interleukin-6 is an autocrine growth factor in human prostate cancer.
11733366 2001
×
Entrez Id: 3569
Gene Symbol: IL6
IL6
Prostatic Neoplasms
0.400
AlteredExpression
LHGDN
Depletion of intracellular zinc increases expression of tumorigenic cytokines VEGF, IL-6 and IL-8 in prostate cancer cells via NF-kappaB-dependent pathway.
18615482 2008
×
Entrez Id: 3569
Gene Symbol: IL6
IL6
Prostatic Neoplasms
0.400
Biomarker
LHGDN
Interleukin-6 regulates androgen receptor activity and prostate cancer cell growth.
12431817 2002
×
Entrez Id: 3569
Gene Symbol: IL6
IL6
Prostatic Neoplasms
0.400
AlteredExpression
LHGDN
Hepatocyte growth factor and interleukin-6 in combination with prostate volume are possible prostate cancer tumor markers in patients with gray-zone PSA levels.
17876341 2008
×
Entrez Id: 3569
Gene Symbol: IL6
IL6
Prostatic Neoplasms
0.400
Biomarker
CTD_human
Osteoblasts induce prostate cancer proliferation and PSA expression through interleukin-6-mediated activation of the androgen receptor.
15672864 2004
×
Entrez Id: 3569
Gene Symbol: IL6
IL6
Prostatic Neoplasms
0.400
Biomarker
CTD_human
p38MAPK activation is involved in androgen-independent proliferation of human prostate cancer cells by regulating IL-6 secretion.
17196171 2007
×
Entrez Id: 3569
Gene Symbol: IL6
IL6
Prostatic Neoplasms
0.400
Therapeutic
CTD_human
Niclosamide suppresses cell migration and invasion in enzalutamide resistant prostate cancer cells via Stat3-AR axis inhibition.
25970160 2015
×
Entrez Id: 3569
Gene Symbol: IL6
IL6
Prostatic Neoplasms
0.400
Therapeutic
CTD_human
Interleukin-6 stimulation of growth of prostate cancer in vitro and in vivo through activation of the androgen receptor.
19011039 2009
×
Entrez Id: 3569
Gene Symbol: IL6
IL6
Prostatic Neoplasms
0.400
Therapeutic
CTD_human
Interleukin-6 increases prostate cancer cells resistance to bicalutamide via TIF2.
19240160 2009
×
Entrez Id: 3569
Gene Symbol: IL6
IL6
Prostatic Neoplasms
0.400
Biomarker
CTD_human
Niclosamide suppresses cell migration and invasion in enzalutamide resistant prostate cancer cells via Stat3-AR axis inhibition.
25970160 2015
×
Entrez Id: 3569
Gene Symbol: IL6
IL6
Prostatic Neoplasms
0.400
Biomarker
CTD_human
Interleukin-6 stimulation of growth of prostate cancer in vitro and in vivo through activation of the androgen receptor.
19011039 2009
×
Entrez Id: 3569
Gene Symbol: IL6
IL6
Prostatic Neoplasms
0.400
Therapeutic
CTD_human
p38MAPK activation is involved in androgen-independent proliferation of human prostate cancer cells by regulating IL-6 secretion.
17196171 2007
×
Entrez Id: 3569
Gene Symbol: IL6
IL6
Prostatic Neoplasms
0.400
Biomarker
CTD_human
Interleukin-6 increases prostate cancer cells resistance to bicalutamide via TIF2.
19240160 2009
×
Entrez Id: 3569
Gene Symbol: IL6
IL6
Prostatic Neoplasms
0.400
Therapeutic
CTD_human
Osteoblasts induce prostate cancer proliferation and PSA expression through interleukin-6-mediated activation of the androgen receptor.
15672864 2004
×
Entrez Id: 3569
Gene Symbol: IL6
IL6
Prostatic Neoplasms
0.400
AlteredExpression
BEFREE
Serum IL-6 levels also correlate with prostate tumor burden, prostate-specific antigen levels and metastasis.
24446297 2014
×
Entrez Id: 3569
Gene Symbol: IL6
IL6
Prostatic Neoplasms
0.400
AlteredExpression
BEFREE
Immunohistochemistry studies showed increased levels of STAT3 and IL-6 , but low levels of programmed cell death protein 4 (PDCD4), in prostate tumor epithelial cells compared to adjacent perinormal prostate epithelial cells.
28467474 2017
×
Entrez Id: 3569
Gene Symbol: IL6
IL6
Prostatic Neoplasms
0.400
AlteredExpression
BEFREE
ESE3/EHF and IL-6 were significantly inversely correlated in prostate tumors .
27732936 2016